| Immunotherapy in gastric cancer S Matsueda, DY Graham World journal of gastroenterology: WJG 20 (7), 1657, 2014 | 344 | 2014 |
| NLRX1 negatively regulates TLR-induced NF-κB signaling by targeting TRAF6 and IKK X Xia, J Cui, HY Wang, L Zhu, S Matsueda, Q Wang, X Yang, J Hong, ... Immunity 34 (6), 843-853, 2011 | 292 | 2011 |
| PD‐1 expression on peripheral blood T‐cell subsets correlates with prognosis in non‐small cell lung cancer K Waki, T Yamada, K Yoshiyama, Y Terazaki, S Sakamoto, S Matsueda, ... Cancer science 105 (10), 1229-1235, 2014 | 81 | 2014 |
| Breast cancer cells expressing stem cell markers CD44+ CD24lo are eliminated by Numb-1 peptide-activated T cells T Mine, S Matsueda, Y Li, H Tokumitsu, H Gao, C Danes, KK Wong, ... Cancer immunology, immunotherapy 58, 1185-1194, 2009 | 80 | 2009 |
| Prostate‐specific antigen‐derived epitopes capable of inducing cellular and humoral responses in HLA‐A24+ prostate cancer patients M Harada, K Kobayashi, S Matsueda, M Nakagawa, M Noguchi, K Itoh The Prostate 57 (2), 152-159, 2003 | 77 | 2003 |
| A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma Y Narita, Y Arakawa, F Yamasaki, R Nishikawa, T Aoki, M Kanamori, ... Neuro-oncology 21 (3), 348-359, 2019 | 70 | 2019 |
| A randomized phase II clinical trial of personalized peptide vaccination with metronomic low-dose cyclophosphamide in patients with metastatic castration-resistant prostate cancer M Noguchi, F Moriya, N Koga, S Matsueda, T Sasada, A Yamada, ... Cancer Immunology, Immunotherapy 65, 151-160, 2016 | 69 | 2016 |
| An open-label, randomized phase II trial of personalized peptide vaccination in patients with bladder cancer that progressed after platinum-based chemotherapy M Noguchi, K Matsumoto, H Uemura, G Arai, M Eto, S Naito, C Ohyama, ... Clinical Cancer Research 22 (1), 54-60, 2016 | 58 | 2016 |
| Phase II study of personalized peptide vaccination for previously treated advanced colorectal cancer S Kibe, S Yutani, S Motoyama, T Nomura, N Tanaka, A Kawahara, ... Cancer immunology research 2 (12), 1154-1162, 2014 | 56 | 2014 |
| Personalized peptide vaccination for advanced biliary tract cancer: IL-6, nutritional status and pre-existing antigen-specific immunity as possible biomarkers for patient prognosis M Yoshitomi, S Yutani, S Matsueda, T Ioji, N Komatsu, S Shichijo, ... Experimental and therapeutic medicine 3 (3), 463-469, 2012 | 56 | 2012 |
| Effects of corticosteroids and hyaluronic acid on torn rotator cuff tendons in vitro and in rats H Nakamura, M Gotoh, T Kanazawa, K Ohta, K Nakamura, H Honda, ... Journal of Orthopaedic Research 33 (10), 1523-1530, 2015 | 55 | 2015 |
| A phase II study of a personalized peptide vaccination for chemotherapy-resistant advanced pancreatic cancer patients S Yutani, N Komatsu, M Yoshitomi, S Matsueda, K Yonemoto, T Mine, ... Oncology reports 30 (3), 1094-1100, 2013 | 54 | 2013 |
| Identification of new prostate stem cell antigen-derived peptides immunogenic in HLA-A2+ patients with hormone-refractory prostate cancer S Matsueda, K Kobayashi, Y Nonaka, M Noguchi, K Itoh, M Harada Cancer Immunology, Immunotherapy 53, 479-489, 2004 | 54 | 2004 |
| Phase II study of personalized peptide vaccination for castration‐resistant prostate cancer patients who failed in docetaxel‐based chemotherapy M Noguchi, F Moriya, S Suekane, K Matsuoka, G Arai, S Matsueda, ... The prostate 72 (8), 834-845, 2012 | 53 | 2012 |
| Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients R Takahashi, U Toh, N Iwakuma, M Takenaka, H Otsuka, M Furukawa, ... Breast Cancer Research 16, 1-13, 2014 | 52 | 2014 |
| Identification of peptide vaccine candidates for prostate cancer patients with HLA-A3 supertype alleles S Matsueda, H Takedatsu, A Yao, M Tanaka, M Noguchi, K Itoh, ... Clinical cancer research 11 (19), 6933-6943, 2005 | 51 | 2005 |
| Phase II study of personalized peptide vaccination for refractory bone and soft tissue sarcoma patients R Takahashi, Y Ishibashi, K Hiraoka, S Matsueda, K Kawano, ... Cancer science 104 (10), 1285-1294, 2013 | 50 | 2013 |
| Personalized peptide vaccination in patients with refractory non-small cell lung cancer K Yoshiyama, Y Terazaki, S Matsueda, S Shichijo, M Noguchi, A Yamada, ... International journal of oncology 40 (5), 1492-1500, 2012 | 49 | 2012 |
| Identification of polycomb group protein enhancer of zeste homolog 2 (EZH2)‐derived peptides immunogenic in HLA‐A24+ prostate cancer patients R Ogata, S Matsueda, A Yao, M Noguchi, K Itoh, M Harada The Prostate 60 (4), 273-281, 2004 | 45 | 2004 |
| Measurement and quantitative characterization of whole-body pharmacokinetics of exogenously administered T cells in mice A Khot, S Matsueda, VA Thomas, RC Koya, DK Shah Journal of Pharmacology and Experimental Therapeutics 368 (3), 503-513, 2019 | 43 | 2019 |
